{"id":918283,"date":"2025-12-10T08:06:13","date_gmt":"2025-12-10T13:06:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/"},"modified":"2025-12-10T08:06:13","modified_gmt":"2025-12-10T13:06:13","slug":"absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/","title":{"rendered":"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>Donovan to share his personal journey at Absci\u2019s upcoming Key Opinion Leader seminar<\/em>\n      <\/p>\n<p align=\"justify\">VANCOUVER, Wash. and NEW YORK, Dec.  10, 2025  (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced a partnership with U.S. soccer legend Landon Donovan to elevate the voices of those living with androgenetic alopecia (AGA) and shine a light on the emotional impact of hair loss.<\/p>\n<p align=\"justify\">Donovan will join Absci\u2019s virtual <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QRaELDE8cfsOFfa9BMs_ADT3tkZty1QMNwrtRWtkYEqvEKZoxJLGDWH2N1P7Ehxvm1M710pDzaNEAk-zgUJkktsBIHFBCpfWC7XsGrHJVmZtFSPV_euoPFK8wyN80JDAyvzCiilfQ5CgSFdVM8fGk-7RcFFT99AfHdXCuko-bt7D_UHKQjeW0kSv-w6XozQsldwrbZks1C-0gEYQi3HldhEXx47KKQVdw3_i3zGgLbUMlesb2SRPhTtnwfHScTg_\" rel=\"nofollow\" target=\"_blank\"><u>KOL seminar on Thursday, December 11<\/u><\/a> to speak about his patient experience and the need for better treatment options, providing patient-driven context for the design and development of the investigational antibody, ABS-201.<\/p>\n<p align=\"justify\">\u201cFor years, I felt like I had to suffer in silence because hair loss is often dismissed as just a vanity issue. But the reality is that losing your hair can feel like losing a piece of your identity,\u201d said Landon Donovan, former U.S. Men\u2019s National Team captain. \u201cI know the frustration of looking in the mirror, trying products that don\u2019t work, and feeling like there is no real solution. I\u2019m sharing my story to let others know they aren\u2019t alone, and to support the work Absci is doing to finally bring a science-first approach to a condition that affects so many of us.\u201d<\/p>\n<p align=\"justify\">\u201cWe believe that developing breakthrough medicines starts with listening to the people who need them,\u201d said Sean McClain, Founder and CEO of Absci. \u201cLandon\u2019s story is a powerful reminder that behind every data point is a person struggling with self-confidence and mental health. This partnership reinforces our commitment to improving the lives of patients who have been waiting too long for innovation.\u201d<\/p>\n<p align=\"justify\">Absci will be hosting a virtual <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lup9UVayYCbGDP1XtjVZBhq8yiZzqVtpYjVOEy3sNarXS3ynILJuXI4WhqvWZhiFfys1EaPDbJ5EegOYCbJxqiHMndh8fVWHMEZ87jYa9CIVmoFYyEEPe8GsmJnZplzjj9NQ6mb4txQoLYVGrOzEk8qpNlnNHy8-L8LVqKlJsNqZetKpp65sD5iH6pfoXh9Yhmja1PNqOba2evr3O70XqLqtkfZcHnlgk94-4ekH6W2Ru3QvRC_-tbXF7itckZkz\" rel=\"nofollow\" target=\"_blank\"><u>seminar on Thursday, December 11<\/u><\/a> with leading dermatology and hair research experts to discuss the anticipated clinical development path, market opportunity, and differentiated profile of AI designed antibody ABS-201. The company will also disclose additional, new human <em>ex vivo<\/em> data that further support the PRLR mechanism of action underlying this program. Landon Donovan will join the seminar to share his personal struggles with hair loss and the human impact of androgenetic alopecia.<\/p>\n<p align=\"justify\">\n        <strong>About ABS-201 and Androgenetic Alopecia<\/strong><br \/>\n        <br \/>Androgenetic alopecia, commonly known as male-pattern or female-pattern hair loss, affects approximately 80 million Americans. The condition causes crown balding and receding hairlines in men, and progressive hair thinning in women. Currently, the only FDA-approved treatments \u2013 minoxidil and finasteride \u2013 show limited efficacy and notable side effects, leaving patients with limited therapeutic options.<\/p>\n<p align=\"justify\">ABS-201 represents a novel therapeutic approach targeting prolactin receptors to stimulate hair follicle regeneration and promote durable hair regrowth as demonstrated in <em>in vivo<\/em> studies. In preclinical studies, the antibody demonstrated statistically significant superior hair regrowth compared to minoxidil in a preclinical mouse model. Absci anticipates an interim data readout from its Phase 1\/2a HEADLINE study in the second half of 2026.<\/p>\n<p align=\"justify\">\n        <strong>About Absci<\/strong><br \/>\n        <br \/>Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation\u2122 platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci\u2019s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern hair-loss. ABS-201 is also being investigated as a potential \u201cbest-in-class\u201d therapeutic for endometriosis, a condition with significant unmet medical need and market potential. Absci is headquartered in Vancouver, WA, with an AI Research Lab in New York City, and Innovation Center in Switzerland. Learn more at www.absci.com or follow us on LinkedIn (@absci), X (@Abscibio) and YouTube.<\/p>\n<p align=\"justify\">Absci\u00ae standard character mark, ABS-201\u2122, Headline\u2122 and Integrated Drug Creation\u2122 are trademarks and registered trademarks of Absci Corporation.<\/p>\n<p align=\"justify\">\n        <strong>Absci Forward Looking Statements<\/strong><br \/>\n        <br \/>Statements contained in this press release regarding matters that are not historical facts are \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding any or all of the following: (i) Absci\u2019s preclinical studies, clinical trials, as well as partnered and internally developed programs, including, without limitation, manufacturing capabilities, status of such studies and trials and expectations regarding data, safety and efficacy generally; (ii) data included in the above-described oral presentation, as well as the ability to use data from ongoing and planned clinical trials for the design and initiation of further clinical trials; (iii) Absci\u2019s strategy, goals, anticipated financial performance and the sufficiency of its cash resources; (iv) regulatory submissions and authorizations, including timelines for and expectations regarding any anticipated regulatory agency decisions; (v) the expected benefits of its collaborations with partners; and (vi) the therapeutic value, development, and commercial potential of antibody therapies, as well as other technologies. Risks that contribute to the uncertain nature of the forward-looking statements include, without limitation, the risks and uncertainties discussed under the heading \u201cRisk Factors\u201d in Absci Corporation\u2019s most recent annual report on Form 10-K and in any other subsequent filings made by Absci Corporation with the U.S. Securities and Exchange Commission. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by law.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Alex Khan<br \/>VP, Finance &amp; Investor Relations<br \/>investors@absci.com<\/p>\n<p align=\"justify\">\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>press@absci.com<br \/>absci@methodcommunications.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MThjZWU3MTgtMzBkNi00NmNlLTlmYzQtNGRiMmFkODk1NmYyLTEyMjE2MzMtMjAyNS0xMi0xMC1lbg==\/tiny\/ABSCI-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci\u2019s upcoming Key Opinion Leader seminar VANCOUVER, Wash. and NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced a partnership with U.S. soccer legend Landon Donovan to elevate the voices of those living with androgenetic alopecia (AGA) and shine a light on the emotional impact of hair loss. Donovan will join Absci\u2019s virtual KOL seminar on Thursday, December 11 to speak about his patient experience and the need for better treatment options, providing patient-driven context for the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-918283","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci\u2019s upcoming Key Opinion Leader seminar VANCOUVER, Wash. and NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced a partnership with U.S. soccer legend Landon Donovan to elevate the voices of those living with androgenetic alopecia (AGA) and shine a light on the emotional impact of hair loss. Donovan will join Absci\u2019s virtual KOL seminar on Thursday, December 11 to speak about his patient experience and the need for better treatment options, providing patient-driven context for the &hellip; Continue reading &quot;Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-10T13:06:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research\",\"datePublished\":\"2025-12-10T13:06:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/\"},\"wordCount\":1030,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/\",\"name\":\"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=\",\"datePublished\":\"2025-12-10T13:06:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/","og_locale":"en_US","og_type":"article","og_title":"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Market Newsdesk","og_description":"Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci\u2019s upcoming Key Opinion Leader seminar VANCOUVER, Wash. and NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) &#8212; Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced a partnership with U.S. soccer legend Landon Donovan to elevate the voices of those living with androgenetic alopecia (AGA) and shine a light on the emotional impact of hair loss. Donovan will join Absci\u2019s virtual KOL seminar on Thursday, December 11 to speak about his patient experience and the need for better treatment options, providing patient-driven context for the &hellip; Continue reading \"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-10T13:06:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research","datePublished":"2025-12-10T13:06:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/"},"wordCount":1030,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/","name":"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=","datePublished":"2025-12-10T13:06:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5OTc4NCM3MzE0ODQ3IzIyMTAwODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-and-u-s-soccer-legend-landon-donovan-partner-to-champion-the-patient-voice-in-hair-loss-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/918283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=918283"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/918283\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=918283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=918283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=918283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}